As I understand one of the main reasons dimerix listing attempt was unsuccessful was because they didn't have an approved patent yet which now they have. It is far more derisked now. The track record of Forrest capital is good. They also have 60mill option reasons for this company's share price to do well. I'm reasonably confident we'll see significant share price growth over the next few months.
- Forums
- ASX - By Stock
- SBN
- Ann: Trading Halt
Ann: Trading Halt, page-21
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online